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INTRODUCTION
Guidelines recommend primary care physicians (PCPs) offer
patients a choice of colorectal cancer (CRC) screening
methods, including colonoscopy and fecal occult blood tests
(FOBT).1 However, in countries like the USA and Switzer-
land, patients are screened almost exclusively with colonos-
copy.2, 3 When offered both tests, patients appear as likely to
choose one as the other; the predominance of colonoscopy
may largely be explained by physician preference and local
medical culture.4 Offering only colonoscopy might explain
why screening rates are low.
We sought to determine the proportions of patients who
opted for screening with colonoscopy or FOBT and who
refused testing among 50–75 year olds eligible for screening
at a PCP visit. We described variation in care between PCPs
and tried to identify PCP-level factors associated with testing
method and refusal.
METHODS
We conducted a cross-sectional data collection on CRC screen-
ing practices at PCP level.We invited 129 PCPs from the Swiss
Sentinel Surveillance Network (Sentinella) to fill a structured
data collection form for 40 consecutive non-emergent consul-
tations with 50–75-year-old patients. The federal office of
public health (FOPH) provided demographic data at PCP level.
PCPs reported demographic data at patient-level, data on pre-
vious CRC tests, contraindications for screening, risk factors
for CRC, if CRC screening was discussed, choice of test
(colonoscopy, FOBT, other), and refusal for testing. We calcu-
lated overall proportions and reported variation between PCPs
in the proportion of FOBT vs. colonoscopy they prescribed to
patients who chose to be tested. We calculated overall prescrip-
tion rates of FOBT vs. colonoscopy for each PCP, including
both patients who had already undergone screening and pa-
tients prescribed screening after the consultation. We dichoto-
mized this covariate by never-prescription of FOBT (no pa-
tients previously tested with FOBT or prescribed FOBT after
discussion) vs. any FOBT.
We used mixed-effects logistic regression models that
allowed us to cluster the data by PCP (with PCPs modeled
as a random effect) to explore the association between PCP
characteristics and the proportion of patients who refused
screening after discussion. We adjusted the models for PCPs’
demographics (age, sex) and language region, for patients’
demographics (age, sex), and PCPs’ prescription patterns.
RESULTS
Ninety-one PCPs (71% of invited, mean age 54, 24% women)
collected data on 3637 patients. One hundred eighty-six pa-
tients were excluded because they were not aged 50–75 years
old or had already been seen during data collection. The
analysis included 3453 patients (mean age 63, 50% women).
PCPs discussed screening with 51% (874/1727) of eligible
patients (not up-to-date and no contraindications for testing)
(Fig. 1). After excluding patients with risk factors or symp-
toms suggestive of CRC (n = 104), 61% (473/770) opted for
screening (FOBT/colonoscopy ratio 0.5), 29% refused, 6%
were undecided, and 3% were unspecified or missing. Most
patients who refused screening said they did so because they
did not feel concerned.
Thirty-three PCPs (36%) had none of their patients previ-
ously tested with FOBT or who planned to be tested with
FOBT. Patients of PCPs who only offered colonoscopy were
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more likely to refuse screening than patients of PCPs who
offered both colonoscopy and FOBT (44% vs. 20%, respec-
tively, Fig. 2). These results were confirmed in our mixed-
effects multivariate model (OR 3.90, 95%CI 1.90 to 8.00,
p < 0.001). No other PCP characteristics were associated with
chosen testing methods or refusal rates.
DISCUSSION
When PCPs discussed CRC screening with their 50–75-
year-old patients who were not up-to-date with screening,
had no contraindication, and no risk factors for CRC, a
third of their patients declined to be screened. PCPs who
only offered colonoscopy had lower screening rates (47%
Figure 1 Flowchart of 40 consecutive patients aged 50–75 included by PCPs from the Sentinella network in 2017. PCPs collected data on 40
consecutive patients aged 50–75 from on past screening status, contraindications for screening, if a discussion on CRC screening could take
place, RF and symptoms for CRC, and the decision taken (refusal, FOBT, colonoscopy, other). Data collected between April and December
2017. aRF, risk factor for CRC.
Figure 2 Decision patterns among patients who had a discussion on CRC screening (N patients = 770) and included by PCPs who only
prescribed colonoscopy (N = 33) vs. PCPs who prescribed both colonoscopy and FOBT (N = 58), in the Sentinella Network in 2017. Patients
with risk factors or symptoms suggestive for CRC (n = 104) (see Fig. 1) excluded of this analysis.
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vs. 71%) and higher refusal rates (44% vs. 20%) than
PCPs who offered both colonoscopy and FOBT. These
results are in line with a randomized controlled trial
showing lower uptake rates of CRC screening tests
among patients who are offered only colonoscopy vs.
among the ones who are offered both FOBT and colo-
noscopy.5 We were inherently limited in considering ad-
ditional patient-level sociodemographic factors by the
simplicity and anonymity of our data collection.
Encouraging PCPs to offer both methods could reduce the
number of physicians who only prescribe one screening mo-
dality, reduce variation between practices, and allow more
patients to choose the test that matches their preferences and
values.4, 6 This could reduce the number of refusals, raise CRC
screening rates, and ultimately lower the burden of CRC.
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